FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AIGAMERICAN INTERNATIONAL GROUP, INC.

Inspect →

AIIAmerican Integrity Insurance Group, Inc.

Inspect →

AIIAAI Infrastructure Acquisition Corp.

Inspect →

AIIOROBO.AI INC.

Inspect →

AIIRAIR Global PLC

Inspect →

AIJTYJianpu Technology Inc.

Inspect →

AILIHAmeren Illinois Co

Inspect →

AIMAIM ImmunoTech Inc.

Inspect →

AIMDAinos, Inc.

Inspect →

AINALBANY INTERNATIONAL CORP /DE/

Inspect →

AIOVirtus Artificial Intelligence & Technology Opportunities Fund

Inspect →

AIOKAI OKTO Corp.

Inspect →

03 / FINANCIAL CHANGES

Mirum Pharmaceuticals, Inc. MIRM

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-03 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2025-09-30.

Revenue185.72

USD million

Change year over year: +52.71 · +39.6%

Net income-40.77

USD million

Change year over year: -43.67

Operating cash flow-4.31

USD million

Change year over year: -43.99

Total liabilities1,080.80

USD million

Change year over year: +587.73

Total assets1,026.61

USD million

Change year over year: +241.50

Liabilities / assets: 105.3% · Change: +42.5 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-25 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2024-12-31.

Revenue521.31

USD million

Change year over year: +184.42 · +54.7%

Net income-23.36

USD million

Change year over year: +64.58

Operating cash flow55.83

USD million

Change year over year: +45.50

Total liabilities528.12

USD million

Change year over year: +83.01

Total assets842.81

USD million

Change year over year: +172.06

Liabilities / assets: 62.7% · Change: -3.7 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
NUVB ↗	2025-12-31	62.90	-325.3%	-275.7%
DSGN ↗	2025-12-31	0.00	—	—
LYEL ↗	2025-12-31	0.04	-762,355.6%	-416,733.3%
RPRX ↗	2025-12-31	2,378.19	32.4%	104.7%
HRMY ↗	2025-12-31	868.45	18.3%	40.1%
ARQT ↗	2025-12-31	372.07	-4.3%	-1.5%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

RLAY ↗

Relay Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

TPL ↗

Texas Pacific Land Corp

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

NUVB ↗

Nuvation Bio Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

DSGN ↗

Design Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

OZ ↗

Belpointe PREP, LLC

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

LYEL ↗

Lyell Immunopharma, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ADEA ↗

Adeia Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RPRX ↗

Royalty Pharma plc

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

HRMY ↗

Harmony Biosciences Holdings, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RYM ↗

RYTHM, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

GTBIF ↗

Green Thumb Industries Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

SLQT ↗

SelectQuote, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →